Investing Ideas
/
Global Pharmaceuticals & Biotech Can They Turn the Tide

Header cover image

Global Pharmaceuticals & Biotech Can They Turn the Tide

UPDATED Jun 15, 2024

Annually loss-making mid-caps and large-caps with sound financial health.

61 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	VKTX Viking Therapeutics	US$52.02	-7.1%	146.8%	US$5.7b	US$112.72	PB6.1x	E4.8%	n/a
	KDNY Chinook Therapeutics	US$40.39	0.3%	95.7%	US$2.9b	US$40.09	PS495.8x	E22.6%	n/a
	PCVX Vaxcyte	US$72.94	2.8%	42.6%	US$7.9b	US$103.14	PB4x	E1.3%	n/a
	NTLA Intellia Therapeutics	US$25.15	10.6%	-44.0%	US$2.4b	US$70.72	PS46.1x	E33.4%	n/a
	ARWR Arrowhead Pharmaceuticals	US$25.84	8.1%	-27.0%	US$3.2b	US$52.43	PS90.5x	E40.3%	n/a
	APGE Apogee Therapeutics	US$41.14	-1.3%	n/a	US$2.4b	US$84.83	PB3x	E-24.5%	n/a
	MLTX MoonLake Immunotherapeutics	US$41.41	-0.6%	58.8%	US$2.7b	US$73.31	PB4.8x	E2.9%	n/a
	ACLX Arcellx	US$54.41	7.1%	52.0%	US$2.9b	US$79.93	PS22.1x	E-4.2%	n/a
	CRSP CRISPR Therapeutics	US$63.56	9.8%	10.1%	US$5.4b	US$86.57	PS19.9x	E43.0%	n/a
	TWST Twist Bioscience	US$49.84	-1.2%	172.2%	US$2.9b	US$45.56	PS10.5x	E21.7%	n/a
	AZTA Azenta	US$53.91	-0.07%	17.1%	US$2.9b	US$62.60	PS4.5x	E83.8%	0%
	DICE DICE Therapeutics	US$47.55	0.2%	131.2%	US$2.3b	US$48.00	PB4.4x	E-22.3%	n/a
	CERE Cerevel Therapeutics Holdings	US$41.54	3.8%	22.1%	US$7.6b	US$44.78	PB13.4x	E13.6%	n/a

Page 3 of 3